Tuesday, November 24, 2009, 5:46am EST - Canadian Markets open in 3 hours and 44 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Neurogen Corp. (NRGN)

 On Nov 23: 0.18 USD   0.00 (0.00%)  
MORE ON NRGN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Neurogen Corporation (NGM:NRGN) Delayed quote dataEdit
Last Trade: 0.18 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 0.18
Open: N/A
Bid: 0.05 x 1000
Ask: 0.26 x 600
1y Target Est: 9.50
Day's Range: N/A - N/A
52wk Range: 0.06 - 2.07
Volume: 0
Avg Vol (3m): 552,435
Market Cap: 12.43M
P/E (ttm): N/A
EPS (ttm): -1.41
Div & Yield: N/A (N/A%)
Neurogen Corp. (NRGN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add NRGN to Portfolio   Download Data

HEADLINES
• NEUROGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Nov 18)
• NEUROGEN CORP Financials
EDGAR Online Financials (Fri, Nov 13)
• New Star Analyst Rankings for Neurogen Corporation
StarMine (Tue, Nov 10)
• NEUROGEN CORP Files SEC form 10-Q/A, Quarterly Report
EDGAR Online (Mon, Nov 9)
• Neurogen Corporation Earnings Call scheduled for 8:30 am ET today
CCBN (Fri, Nov 6)
• NEUROGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Con
EDGAR Online (Fri, Nov 6)
• Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations
Business Wire (Fri, Nov 6)
• Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6
Business Wire (Wed, Nov 4)
• NEUROGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta
EDGAR Online (Mon, Aug 24)
• Neurogen Corporation Earnings Call scheduled for 5:00 pm ET today
CCBN (Fri, Aug 14)
More Headlines for NRGN...
ANALYST
EPS Est (next year) (Dec-07) : -1.38
EPS Est (in 2 years) (Dec-08) : -1.46
Avg Rec (current)*: 1.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Neurogen Corporation operates as a drug discovery and development company focusing on new small molecule drugs for various disorders, including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrome (RLS), and depression/anxiety.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices